Skip to content

HERON THERAPEUTICS, INC. /DE/: filings

Every HERON THERAPEUTICS, INC. /DE/ annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-10fiscal Q2 2026411130001193125-26-341301
10-Q2026-05-11fiscal Q1 202639820001193125-26-215755
10-K2026-02-26fiscal FY 2025481260001193125-26-073515
10-Q2025-11-04fiscal Q3 2025421200001193125-25-263618
10-Q2025-08-08fiscal Q2 2025401110000950170-25-105475
10-Q2025-05-06fiscal Q1 202540820000950170-25-063971
10-K2025-02-27fiscal FY 2024481240000950170-25-028374
10-Q2024-11-12fiscal Q3 2024401170000950170-24-124698
10-Q2024-08-06fiscal Q2 2024401110000950170-24-091764
10-Q2024-05-07fiscal Q1 202440810000950170-24-053964
10-K2024-03-12fiscal FY 202348970000950170-24-029951
10-Q2023-11-14fiscal Q3 2023401170000950170-23-063714
10-Q2023-08-14fiscal Q2 2023391070000950170-23-042431
10-Q2023-05-11fiscal Q1 202338790000950170-23-021237
10-K2023-03-29fiscal FY 202246910000950170-23-010603
10-Q2022-11-08fiscal Q3 2022391110001564590-22-037047
10-Q2022-08-09fiscal Q2 2022391050001564590-22-028599
10-Q2022-05-09fiscal Q1 202234700001564590-22-018877
10-K2022-02-28fiscal FY 2021411020001564590-22-007618
10-Q2021-11-03fiscal Q3 202134950001564590-21-053953
10-Q2021-08-09fiscal Q2 202134890001564590-21-042362
10-Q2021-05-10fiscal Q1 202133690001564590-21-025796
10-K2021-02-24fiscal FY 2020421530001564590-21-007841
10-Q2020-11-05fiscal Q3 202035960001564590-20-050911
10-Q2020-08-05fiscal Q2 202035900001564590-20-036822
10-Q2020-05-06fiscal Q1 202035710001564590-20-021575
10-K2020-03-02fiscal FY 2019441620001564590-20-007973
10-Q2019-11-12fiscal Q3 201936980001564590-19-042638
10-Q2019-08-05fiscal Q2 201935890001564590-19-028537
10-Q2019-05-09fiscal Q1 201936720001193125-19-142333
10-K2019-02-22fiscal FY 2018411480001193125-19-047780
10-Q2018-11-07fiscal Q3 201832840001193125-18-320941
10-Q2018-08-08fiscal Q2 201832840001193125-18-242064
10-Q2018-05-10fiscal Q1 201832660001193125-18-158506
10-K2018-02-27fiscal FY 2017411390001193125-18-060951
10-Q2017-11-06fiscal Q3 201730720001193125-17-333663
10-Q2017-08-09fiscal Q2 201727660001193125-17-252860
10-Q2017-05-10fiscal Q1 201728560001193125-17-165100
10-K2017-02-23fiscal FY 2016371250001193125-17-054088
10-Q2016-11-08fiscal Q3 201628700001193125-16-763038
10-Q2016-08-08fiscal Q2 201626640001193125-16-675250
10-Q2016-05-05fiscal Q1 201627530001193125-16-579939
10-K2016-02-19fiscal FY 2015321190001193125-16-469890
10-Q2015-11-06fiscal Q3 201523600001193125-15-370016
10-Q2015-08-07fiscal Q2 201523600001193125-15-282886
10-Q2015-05-08fiscal Q1 201523480001193125-15-179414
10-K2015-03-13fiscal FY 2014321200001193125-15-091072
10-Q2014-11-06fiscal Q3 201422560001193125-14-400994
10-Q2014-08-04fiscal Q2 201423600001193125-14-292999
10-Q2014-05-12fiscal Q1 201424500001193125-14-194964
10-K2014-03-07fiscal FY 201331970001193125-14-087658
10-Q2013-11-12fiscal Q3 201324590001193125-13-437144
10-Q2013-08-08fiscal Q2 201323580001193125-13-325343
10-Q2013-05-10fiscal Q1 201324500001193125-13-213597
10-K2013-03-01fiscal FY 201230920001193125-13-085823
10-Q2012-11-05fiscal Q3 201224590001193125-12-451641
10-Q2012-08-09fiscal Q2 201225580001193125-12-346661
10-Q2012-05-10fiscal Q1 201225490001193125-12-224867
10-K2012-03-26fiscal FY 201129710001193125-12-132146
10-Q2011-11-07fiscal Q3 201126630001193125-11-299888
10-Q2011-08-08fiscal Q2 201126610001193125-11-214321

Inspect the source

Entity
HERON THERAPEUTICS, INC. /DE/ / CIK 0000818033
Captured
2026-09-19T15:07:01.978Z
SEC response SHA-256
8fd25ff077a16f81184199b9f7eb0d0d01ac0f8ba4c3b98a3b2cdfc2ad777b2a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000818033.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))